Clinical Evaluation of Different Bioactive Restorative Materials for Cervical Carious in High Caries Risk Patients
Launched by CAIRO UNIVERSITY · Dec 13, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Bioactive restorative materials are relatively new concept in dentistry combines between esthetics, strength and resilience of composites with bioactive properties, the development of therapeutic bio-interactive materials results in tissue re-mineralization, reduces the susceptibility to tooth mineral loss, and recovers its mechanical properties .
Patients, with high caries, have many risk factors like inadequate biofilm control, salivary flow deficiency, and altered host defense. Conventional restorative materials expose the tooth structure to stress concentration. Moreover, preserving th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient age range from 25-45 year.
- • High risk caries.
- • Patients required at least a couple of Class V restorations.
- • The depth of lesion should be(1.5- 2 mm) .
- • The patient should have good general health
- Exclusion Criteria:
- • Poor oral hygiene.
- • Sever or chronic periodontal disease or Bruxism.
- • Severe tooth sensitivity.
- • Non-vital or fracture or cracked teeth.
- • Defective restorations, orthodontic treatment or bleaching procedures during the last 6 months.
- • pregnancy, and/or lactation, and allergy to the main components of the products to be used in the study
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ashraf Nasr, professor
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported